Table 1.

Prevalence of selected prescribing and comorbidities in people with CKD (reanalysis of existing dataset)

Drug or Condition with Clinically Important NSAID InteractionAged <65 yr (N=5159)a (%)Aged ≥65 yr (N=28,412) (%)
Current diureticb38.557.8
Current RASIb52.657.3
Current diuretic and RASIb26.837.0
Current antiplateletb32.752.6
Current oral anticoagulationb3.88.3
Cardiovascular diseasec24.750.6
Heart failure6.014.3
Any of the above73.890.8
Two or more of the above48.073.7
  • RASI, renin-angiotensin system inhibitor.

  • a Reanalysis of data for 33,571 people recorded as having CKD in primary care medical records in Scotland (9).

  • b Current prescribing = prescription issued in last 84 d (either an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker).

  • c Coronary heart disease, stroke, transient ischemic attack, or peripheral vascular disease.